Editor - Kai-Uwe Kern | Institute of Pain Medicine / Pain Practi | 12870
ISSN: 2167-0846

Journal of Pain & Relief
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Kai-Uwe Kern

Kai-Uwe Kern
Kai-Uwe Kern, MD
Institute of Pain Medicine / Pain Practice Wiesbaden


Uwe Kern started his specialisation in pain medicine in 1991 and has worked solely in this field since 2003. He specialised in medical educational steps as a general practioner (family medicine) in 1991, followed by a qualification in anesthesiology in1995. After one year in social medicine as a consultant of the medical health insurance in Koblenz, Germany, he returned to anaesthesiology in 1996 as a senior physician (Kemperhof Medicine Center, Koblenz). After having built up a Pain Medicine Unit for ambulatory and in-patients including a day unit, he became the Head of Pain Medicine at the German Clinic for Diagnosis (DKD), in Wiesbaden, from 2003 to 2005.

Dr. Kern initiated several investigator-driven studies on botulinum toxin, phantom pain, and artificial limb hyperhidrosis and was principal investigator in studies concerning opioids, anticonvulsants, migraine, neuropathic pain and post therapeutic neuralgia. He has published several papers and given national and international lectures on phantom pain, neuropathic pain, trigger points, myofascial pain syndrome, botulinum toxin, topical therapy and post therapeutic neuralgia. He is a co-author of two expert consensus statements and member of several pharmaceutical advisory boards.

Research Interest

Phantom pain
Neuropathic pain
Botulinum toxin
Myofascial trigger pionts
new substances
Pain modulation



Global Speakers in the subject

Global Experts in the subject